But the FDA quashed advocates’ dreams on Aug. 9, saying MDMA cannot be approved based on the data currently available and ...
New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in the brain, synchronizing disrupted neural circuits.
Analysts consider AtaiBeckley’s MDMA candidate a “high-risk, high-reward” bet after the drug demonstrated reductions in ...
Transcend Therapeutics has glided over the bar for success, linking its MDMA analog to improvements in post-traumatic stress disorder (PTSD) symptoms that began on Day 8 and persisted through Day 64 ...
MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...
Under the agreement, PharmAla will provide its LaNeo™ MDMA at no charge to Spaulding Rehabilitation for use in a study entitled “Hyperscan Neuroimaging to Reveal the Brain Mechanisms Supporting ...
TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and ...
Anonymous survey with optional confidential interviews will document how practitioners facilitate MDMA-assisted couples therapy Findings to inform ethical guidelines, future clinical trial protocols, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results